跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“CD166”
全部
47
临床试验
21
药物
18
机构
0
资讯
8
2年前
Radiopharmaceutical Antibody-Drug Conjugates (rADCs) Emerge as Promising Cancer Therapies
9个月前
HER2-Negative Breast Cancer Pipeline Expands with 75+ Therapies from 70+ Companies
去年
CD163+ Tumor-Associated Macrophages Linked to Improved Nivolumab Outcomes in Metastatic Renal Cell Carcinoma
10个月前
Novel Monoclonal Antibody F9H4 Prevents CD16a/b Shedding to Enhance NK Cell-Mediated Cancer Immunotherapy
去年
Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Anti-CD163 Monoclonal Antibody for Cancer Treatment
9个月前
ProBioGen Partners with Spica Therapeutics to Advance First-in-Class Anti-CD163 Antibody ST101 for Cancer Immunotherapy
6个月前
Immunitas Therapeutics to Present First-in-Human Data for Novel Anti-CD161 Antibody IMT-009 at AACR 2026
去年
Immunitas Therapeutics Unveils Promising Preclinical Data for First-in-Class Anti-CD161 Antibody IMT-380 in Autoimmune Diseases